Transition-Metal Catalyzed Synthesis of Pyrimidines: Recent Advances, Mechanism, Scope and Future Perspectives

Overview

Journal Top Curr Chem (Cham)

Publisher Springer

Specialty Chemistry

Date 2024 Jan 31

PMID 38296918

Authors

Vipin K Maikhuri

Divya Mathur

Ankita Chaudhary

Rajesh Kumar

Virinder S Parmar

Brajendra K Singh

Affiliations

Soon will be listed here.

Abstract

Pyrimidine is a pharmacologically important moiety that exhibits diverse biological activities. This review reflects the growing significance of transition metal-catalyzed reactions for the synthesis of pyrimidines (with no discussion being made on the transition metal-catalyzed functionalization of pyrimidines). The effect of different catalysts on the selectivity/yields of pyrimidines and catalyst recyclability (wherever applicable) are described, together with attempts to illustrate the role of the catalyst through mechanisms. Although several methods have been researched for synthesizing this privileged scaffold, there has been a considerable push to expand transition metal-catalyzed, sustainable, efficient and selective synthetic strategies leading to pyrimidines. The aim of the authors with this update (2017-2023) is to drive the designing of new transition metal-mediated protocols for pyrimidine synthesis.

References

Kerru N, Gummidi L, Maddila S, Gangu K, Jonnalagadda S . A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications. Molecules. 2020; 25(8). PMC: 7221918. DOI: 10.3390/molecules25081909. View

Zhuang J, Ma S . Recent Development of Pyrimidine-Containing Antimicrobial Agents. ChemMedChem. 2020; 15(20):1875-1886. DOI: 10.1002/cmdc.202000378. View

Kilic-Kurt Z, Ozmen N, Bakar-Ates F . Synthesis and anticancer activity of some pyrimidine derivatives with aryl urea moieties as apoptosis-inducing agents. Bioorg Chem. 2020; 101:104028. DOI: 10.1016/j.bioorg.2020.104028. View

Blokhina S, Sharapova A, Olkhovich M, Doroshenko I, Levshin I, Perlovich G . Synthesis and antifungal activity of new hybrids thiazolo[4,5-d]pyrimidines with (1H-1,2,4)triazole. Bioorg Med Chem Lett. 2021; 40:127944. DOI: 10.1016/j.bmcl.2021.127944. View

Kang D, Zhang H, Wang Z, Zhao T, Ginex T, Luque F . Identification of Dihydrofuro[3,4- d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties. J Med Chem. 2019; 62(3):1484-1501. PMC: 7441537. DOI: 10.1021/acs.jmedchem.8b01656. View

Noviello S, Huang D, Corey G . Iclaprim: a differentiated option for the treatment of skin and skin structure infections. Expert Rev Anti Infect Ther. 2018; 16(11):793-803. DOI: 10.1080/14787210.2018.1536545. View

Burger J, Barr P, Robak T, Owen C, Ghia P, Tedeschi A . Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study. Leukemia. 2019; 34(3):787-798. PMC: 7214263. DOI: 10.1038/s41375-019-0602-x. View

Luo L, Carson J, Dhanak D, Jackson J, Huang P, Lee Y . Mechanism of inhibition of human KSP by monastrol: insights from kinetic analysis and the effect of ionic strength on KSP inhibition. Biochemistry. 2004; 43(48):15258-66. DOI: 10.1021/bi048282t. View

Brehm J, Scott Y, Koontz D, Perry S, Hammer S, Katzenstein D . Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptase. PLoS One. 2012; 7(2):e31558. PMC: 3283647. DOI: 10.1371/journal.pone.0031558. View

10.

Zhang Y, Cao Y, Li Y, Zhang X . Interactions between Human Serum Albumin and Sulfadimethoxine Determined Using Spectroscopy and Molecular Docking. Molecules. 2022; 27(5). PMC: 8911820. DOI: 10.3390/molecules27051526. View

11.

Lagoja I . Pyrimidine as constituent of natural biologically active compounds. Chem Biodivers. 2006; 2(1):1-50. DOI: 10.1002/cbdv.200490173. View

12.

Kumar S, Narasimhan B . Therapeutic potential of heterocyclic pyrimidine scaffolds. Chem Cent J. 2018; 12(1):38. PMC: 5884769. DOI: 10.1186/s13065-018-0406-5. View

13.

Maikhuri V, Maity J, Srivastava S, Prasad A . Transition metal-catalyzed double C-H bond activation: synthesis of conjugated dienes. Org Biomol Chem. 2022; 20(48):9522-9588. DOI: 10.1039/d2ob01646j. View

14.

Maikhuri V, Khatri V, Kumar A, Singh B, Prasad A . Synthesis of Sugar Diene and Its Pd-Catalyzed Transformation into Chromanes. J Org Chem. 2020; 85(11):7068-7076. DOI: 10.1021/acs.joc.0c00432. View

15.

Trost B, Zuo Z, Schultz J . Transition-Metal-Catalyzed Cycloaddition Reactions to Access Seven-Membered Rings. Chemistry. 2020; 26(67):15354-15377. DOI: 10.1002/chem.202002713. View

16.

Cheung K, Sarkar S, Gevorgyan V . Visible Light-Induced Transition Metal Catalysis. Chem Rev. 2021; 122(2):1543-1625. PMC: 9017709. DOI: 10.1021/acs.chemrev.1c00403. View

17.

Gandeepan P, Muller T, Zell D, Cera G, Warratz S, Ackermann L . 3d Transition Metals for C-H Activation. Chem Rev. 2018; 119(4):2192-2452. DOI: 10.1021/acs.chemrev.8b00507. View

18.

Reen G, Kumar A, Sharma P . Recent advances on the transition-metal-catalyzed synthesis of imidazopyridines: an updated coverage. Beilstein J Org Chem. 2019; 15:1612-1704. PMC: 6664406. DOI: 10.3762/bjoc.15.165. View

19.

Zweig J, Kim D, Newhouse T . Methods Utilizing First-Row Transition Metals in Natural Product Total Synthesis. Chem Rev. 2017; 117(18):11680-11752. DOI: 10.1021/acs.chemrev.6b00833. View

20.

Alig L, Fritz M, Schneider S . First-Row Transition Metal (De)Hydrogenation Catalysis Based On Functional Pincer Ligands. Chem Rev. 2019; 119(4):2681-2751. DOI: 10.1021/acs.chemrev.8b00555. View